Heuro Health chooses Milliman CareFlowIQ’s real-time clinical intelligence to advance obesity care
SEATTLE – January 7th, 2026 –Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, today announced a new client relationship with Heuro Health, a fast-growing obesity and metabolic health provider integrating GLP-1 medications with physician-led, dietitian-supported, and neuroplasticity-based coaching. Through this collaboration, Heuro Health will incorporate Milliman CareFlowIQ’s risk stratification and real-time clinical insights directly into its obesity care platform, strengthening personalized care delivery and enhancing measurable outcomes for members and employers.
By leveraging Milliman CareFlowIQ’s proven clinical intelligence platform, Heuro Health will be able to segment patient populations into medical cohorts to enable customized care. Milliman CareFlowIQ continuously tracks their progress across key biometric and clinical markers, including HbA1c, weight loss trajectories, medication adherence, and comorbidity improvement, to deliver timely, individualized interventions.
“Combining Heuro Health’s science-driven care model with Milliman CareFlowIQ’s clinical intelligence represents a major step forward in personalized, accountable obesity medicine,” said Ben Newton, CEO of Milliman CareFlowIQ. “Using CareFlowIQ, Heuro can identify at-risk populations and monitor progress metric by metric, turning fragmented clinical data into actionable intelligence that improves care delivery and supports long-term metabolic success.”
“I am pleased to be working with Milliman CareFlowIQ. Milliman’s ability to segment patients into the right clinical cohorts allows Heuro to tailor treatment options and medication intensity based on obesity class. This helps employers offer world-class obesity care while keeping treatment aligned with predictable cost models. Together, Heuro and Milliman can monitor patient progress in real time, allowing physicians to adjust care protocols when needed while also demonstrating measurable financial benefits for employers through reduced claims. We expect this partnership with Milliman to take our already impressive results to the next level,” said Jesse Kessler, CEO of Heuro Health. “Using CareFlowIQ, we are bringing precision and accountability to obesity medicine, helping every patient achieve meaningful and measurable change.”
